Arcus Biosciences
RCUS
RCUS
128 hedge funds and large institutions have $756M invested in Arcus Biosciences in 2020 Q3 according to their latest regulatory filings, with 21 funds opening new positions, 56 increasing their positions, 37 reducing their positions, and 31 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
less ownership
Funds ownership: →
less funds holding
Funds holding: →
27% less capital invested
Capital invested by funds: $1.03B → $756M (-$278M)
32% less first-time investments, than exits
New positions opened: 21 | Existing positions closed: 31
50% less funds holding in top 10
Funds holding in top 10: 4 → 2 (-2)
Holders
128
Holding in Top 10
2
Calls
$7.18M
Puts
$1.12M
Top Buyers
| 1 | +$16M | |
| 2 | +$15.8M | |
| 3 | +$13.7M | |
| 4 |
BI
BVF Inc
San Francisco,
California
|
+$12.2M |
| 5 |
BlackRock
New York
|
+$8.4M |
Top Sellers
| 1 | -$43.7M | |
| 2 | -$14.6M | |
| 3 | -$7.71M | |
| 4 |
Holocene Advisors
New York
|
-$6.86M |
| 5 |
Fidelity Investments
Boston,
Massachusetts
|
-$6.08M |